Annals of the Rheumatic Diseases 2022 Full Archives

When it comes to staying informed and up-to-date on the latest research and advancements in rheumatology, the Annals of the Rheumatic Diseases (ARD) is the essential resource for healthcare professionals, researchers, and enthusiasts in the field.

ARD is a renowned international peer-reviewed journal with a commitment to promoting scientific exchange and education in rheumatology. Its comprehensive coverage includes musculoskeletal conditions, arthritic disease, and connective tissue disorders. By publishing basic, clinical, and translational research, ARD provides a platform for groundbreaking discoveries and innovative approaches to patient care.

One of the distinguishing factors of ARD is its adherence to Plan S compliance, making it a Transformative Journal. Plan S compliance means that ARD meets the requirements set forth by cOAlition S funders, such as Wellcome, WHO, and UKRI, for open access publishing. This ensures that the latest research in rheumatology is accessible to a wide audience, facilitating collaboration and driving progress in the field.

ARD is co-owned by the prestigious European Alliance of Associations for Rheumatology (EULAR) and BMJ, further exemplifying its authority and influence in rheumatology. This partnership brings together the expertise and resources of two leading organizations, enhancing the journal’s ability to deliver high-quality content.

As a subscription-based journal, ARD offers a hybrid open access option, allowing authors to choose whether to make their articles freely available or restrict access to subscribers. This approach strikes a balance between accessibility and sustainability, ensuring that the journal can continue to provide valuable insights without compromising its financial stability.

With a monthly publication schedule, ARD keeps readers informed about the latest research findings and clinical developments. Its digital archives, hosted by Portico and LOCKSS, provide a reliable and accessible repository of past issues, ensuring the longevity and accessibility of valuable research.

The rigorous peer review process employed by ARD guarantees the quality and integrity of published articles. By utilizing a single anonymized review model, the journal ensures that the evaluation process is unbiased and objective. This commitment to transparency and scientific rigor strengthens the credibility and impact of the journal.

Whether you are a researcher, clinician, or student, ARD offers a wealth of knowledge and insights that can fuel your own research, inform your clinical practice, or deepen your understanding of rheumatology. Stay up-to-date with the latest advancements, discover key research studies, and explore new perspectives by subscribing to ARD today.